# Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI

> **NCT01135667** · PHASE4 · COMPLETED · sponsor: **Lene Holmvang** · enrollment: 106 (actual)

## Conditions studied

- Coronary Artery Disease
- Percutaneous Coronary Intervention
- Acute Coronary Syndromes

## Interventions

- **DRUG:** clopidogrel
- **DRUG:** Prasugrel 10 mg

## Key facts

- **NCT ID:** NCT01135667
- **Lead sponsor:** Lene Holmvang
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-09
- **Primary completion:** 2012-07
- **Final completion:** 2012-08
- **Target enrollment:** 106 (ACTUAL)
- **Last updated:** 2012-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01135667

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01135667, "Prasugrel Versus Double Dose Clopidogrel to Treat Clopidogrel Low-responsiveness After PCI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01135667. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*